APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

CD19-targeted CAR-T Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global CD19-targeted CAR-T Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173975660326 December 2025184 pages

Choose your research edition.

Industry ResearchCD19-targeted CAR-T Cell Therapy Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal CD19-targeted CAR-T Cell Therapy Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal CD19-targeted CAR-T Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CD19-targeted CAR-T Cell Therapy Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal CD19-targeted CAR-T Cell Therapy Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global CD19-targeted CAR-T Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for CD19-targeted CAR-T Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for CD19-targeted CAR-T Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CD19-targeted CAR-T Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for CD19-targeted CAR-T Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of CD19-targeted CAR-T Cell Therapy include Bristol-Myers Squibb (Breyanzi), Gilead (Yescarta&Tecartus), Novartis (Kymriah), FOSUNKite (Yescarta), Juventas and Shanghai Yaoming Juno (Carteyva), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global CD19-targeted CAR-T Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of CD19-targeted CAR-T Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents CD19-targeted CAR-T Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CD19-targeted CAR-T Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

CD19-targeted CAR-T Cell Therapy Segment by Company

Bristol-Myers Squibb (Breyanzi)

Gilead (Yescarta&Tecartus)

Novartis (Kymriah)

FOSUNKite (Yescarta)

Juventas

Shanghai Yaoming Juno (Carteyva)

CD19-targeted CAR-T Cell Therapy Segment by Type

Yescarta

Tecartus

Kymriah

Others

CD19-targeted CAR-T Cell Therapy Segment by Application

Lymphoma

Lymphocytic Leukemia

CD19-targeted CAR-T Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CD19-targeted CAR-T Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CD19-targeted CAR-T Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CD19-targeted CAR-T Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CD19-targeted CAR-T Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CD19-targeted CAR-T Cell Therapy industry.

Chapter 3: Detailed analysis of CD19-targeted CAR-T Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CD19-targeted CAR-T Cell Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Yescarta Table 3. Key Players of Tecartus Table 4. Key Players of Kymriah Table 3. Key Players of Others Table 4. Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Lymphoma Table 6. Key Players of Lymphocytic Leukemia Table 7. Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global CD19-targeted CAR-T Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 9. Global CD19-targeted CAR-T Cell Therapy Market Share by Region (2021-2026) Table 10. Global CD19-targeted CAR-T Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 11. Global CD19-targeted CAR-T Cell Therapy Market Share by Region (2027-2032) Table 12. CD19-targeted CAR-T Cell Therapy Industry Trends Table 13. CD19-targeted CAR-T Cell Therapy Industry Drivers Table 14. CD19-targeted CAR-T Cell Therapy Industry Opportunities and Challenges Table 15. CD19-targeted CAR-T Cell Therapy Industry Restraints Table 16. Global CD19-targeted CAR-T Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 17. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Company (2021-2026) Table 18. Global CD19-targeted CAR-T Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global CD19-targeted CAR-T Cell Therapy Key Company Head Office and Area Served Table 20. Global CD19-targeted CAR-T Cell Therapy Company, Product Type & Application Table 21. Global CD19-targeted CAR-T Cell Therapy Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global CD19-targeted CAR-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global CD19-targeted CAR-T Cell Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 26. Global CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 27. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Type (2021-2026) Table 28. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Type (2027-2032) Table 29. Global CD19-targeted CAR-T Cell Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 31. Global CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 32. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Application (2021-2026) Table 33. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Application (2027-2032) Table 34. Bristol-Myers Squibb (Breyanzi) Company Information Table 35. Bristol-Myers Squibb (Breyanzi) Business Overview Table 36. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product Portfolio Table 38. Bristol-Myers Squibb (Breyanzi) Recent Development Table 39. Gilead (Yescarta&Tecartus) Company Information Table 40. Gilead (Yescarta&Tecartus) Business Overview Table 41. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product Portfolio Table 43. Gilead (Yescarta&Tecartus) Recent Development Table 44. Novartis (Kymriah) Company Information Table 45. Novartis (Kymriah) Business Overview Table 46. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product Portfolio Table 48. Novartis (Kymriah) Recent Development Table 49. FOSUNKite (Yescarta) Company Information Table 50. FOSUNKite (Yescarta) Business Overview Table 51. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product Portfolio Table 53. FOSUNKite (Yescarta) Recent Development Table 54. Juventas Company Information Table 55. Juventas Business Overview Table 56. Juventas CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Juventas CD19-targeted CAR-T Cell Therapy Product Portfolio Table 58. Juventas Recent Development Table 59. Shanghai Yaoming Juno (Carteyva) Company Information Table 60. Shanghai Yaoming Juno (Carteyva) Business Overview Table 61. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product Portfolio Table 63. Shanghai Yaoming Juno (Carteyva) Recent Development Table 64. North America CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 65. North America CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 66. North America CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 67. North America CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 68. North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026) Table 70. North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032) Table 71. Europe CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026) Table 77. Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032) Table 78. China CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 79. China CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 80. China CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 81. China CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026) Table 88. Asia CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. CD19-targeted CAR-T Cell Therapy Product Image Figure 2. Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global CD19-targeted CAR-T Cell Therapy Market Share by Type: 2025 VS 2032 Figure 4. Yescarta Image Figure 5. Tecartus Image Figure 6. Kymriah Image Figure 7. Others Image Figure 8. Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global CD19-targeted CAR-T Cell Therapy Market Share by Application: 2025 VS 2032 Figure 10. Lymphoma Image Figure 11. Lymphocytic Leukemia Image Figure 12. Global CD19-targeted CAR-T Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 14. Global CD19-targeted CAR-T Cell Therapy Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global CD19-targeted CAR-T Cell Therapy Market Share by Players in 2025 Figure 17. Global Top 5 and 10 CD19-targeted CAR-T Cell Therapy Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global CD19-targeted CAR-T Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Type (2021-2032) Figure 21. Global CD19-targeted CAR-T Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Application (2021-2032) Figure 23. North America CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 24. North America CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032) Figure 25. North America CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032) Figure 26. North America CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032) Figure 27. United States CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Canada CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Mexico CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 31. Europe CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032) Figure 32. Europe CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032) Figure 33. Europe CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032) Figure 34. Germany CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 35. France CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 36. U.K. CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Italy CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Russia CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 41. China CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032) Figure 42. China CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032) Figure 43. Asia CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 44. Asia CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032) Figure 45. Asia CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032) Figure 46. Asia CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032) Figure 47. Japan CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 48. South Korea CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 51. India CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 52. Australia CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032) Figure 57. Brazil CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 58. South Africa CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Turkey CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Argentina CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 62. UAE CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Egypt CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Chile CD19-targeted CAR-T Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Yescarta
  • Tecartus
  • Kymriah
  • Others
Applications
  • Lymphoma
  • Lymphocytic Leukemia
Companies covered
  • Bristol-Myers Squibb (Breyanzi)
  • Gilead (Yescarta&Tecartus)
  • Novartis (Kymriah)
  • FOSUNKite (Yescarta)
  • Juventas
  • Shanghai Yaoming Juno (Carteyva)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Yescarta
  5. 1.2.3 Tecartus
  6. 1.2.4 Kymriah
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Lymphoma
  11. 1.3.3 Lymphocytic Leukemia
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global CD19-targeted CAR-T Cell Therapy Growth Trends by Region
  14. 1.5.1 Global CD19-targeted CAR-T Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 CD19-targeted CAR-T Cell Therapy Market Size by Region (2021-2026)
  16. 1.5.3 CD19-targeted CAR-T Cell Therapy Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global CD19-targeted CAR-T Cell Therapy Market Dynamics
  1. 2.1 CD19-targeted CAR-T Cell Therapy Industry Trends
  2. 2.2 CD19-targeted CAR-T Cell Therapy Industry Drivers
  3. 2.3 CD19-targeted CAR-T Cell Therapy Industry Opportunities and Challenges
  4. 2.4 CD19-targeted CAR-T Cell Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global CD19-targeted CAR-T Cell Therapy Revenue by Company (2021-2026)
  2. 3.2 Global CD19-targeted CAR-T Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global CD19-targeted CAR-T Cell Therapy Key Company Head office and Area Served
  4. 3.4 Global CD19-targeted CAR-T Cell Therapy Company, Product Type & Application
  5. 3.5 Global CD19-targeted CAR-T Cell Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global CD19-targeted CAR-T Cell Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 CD19-targeted CAR-T Cell Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 CD19-targeted CAR-T Cell Therapy Tier 1, Tier 2, and Tier 3
4 CD19-targeted CAR-T Cell Therapy Market by Type
  1. 4.1 Global CD19-targeted CAR-T Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2032)
  3. 4.3 Global CD19-targeted CAR-T Cell Therapy Market Size Share by Type (2021-2032)
5 CD19-targeted CAR-T Cell Therapy Market by Application
  1. 5.1 Global CD19-targeted CAR-T Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2032)
  3. 5.3 Global CD19-targeted CAR-T Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb (Breyanzi)
  2. 6.1.1 Bristol-Myers Squibb (Breyanzi) Company Information
  3. 6.1.2 Bristol-Myers Squibb (Breyanzi) Business Overview
  4. 6.1.3 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb (Breyanzi) Recent Developments
  7. 6.2 Gilead (Yescarta&Tecartus)
  8. 6.2.1 Gilead (Yescarta&Tecartus) Company Information
  9. 6.2.2 Gilead (Yescarta&Tecartus) Business Overview
  10. 6.2.3 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product Portfolio
  12. 6.2.5 Gilead (Yescarta&Tecartus) Recent Developments
  13. 6.3 Novartis (Kymriah)
  14. 6.3.1 Novartis (Kymriah) Company Information
  15. 6.3.2 Novartis (Kymriah) Business Overview
  16. 6.3.3 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product Portfolio
  18. 6.3.5 Novartis (Kymriah) Recent Developments
  19. 6.4 FOSUNKite (Yescarta)
  20. 6.4.1 FOSUNKite (Yescarta) Company Information
  21. 6.4.2 FOSUNKite (Yescarta) Business Overview
  22. 6.4.3 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product Portfolio
  24. 6.4.5 FOSUNKite (Yescarta) Recent Developments
  25. 6.5 Juventas
  26. 6.5.1 Juventas Company Information
  27. 6.5.2 Juventas Business Overview
  28. 6.5.3 Juventas CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Juventas CD19-targeted CAR-T Cell Therapy Product Portfolio
  30. 6.5.5 Juventas Recent Developments
  31. 6.6 Shanghai Yaoming Juno (Carteyva)
  32. 6.6.1 Shanghai Yaoming Juno (Carteyva) Company Information
  33. 6.6.2 Shanghai Yaoming Juno (Carteyva) Business Overview
  34. 6.6.3 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product Portfolio
  36. 6.6.5 Shanghai Yaoming Juno (Carteyva) Recent Developments
7 North America
  1. 7.1 North America CD19-targeted CAR-T Cell Therapy Market Size (2021-2032)
  2. 7.2 North America CD19-targeted CAR-T Cell Therapy Market Size by Type
  3. 7.2.1 North America CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032)
  6. 7.3 North America CD19-targeted CAR-T Cell Therapy Market Size by Application
  7. 7.3.1 North America CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032)
  10. 7.4 North America CD19-targeted CAR-T Cell Therapy Market Size by Country
  11. 7.4.1 North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe CD19-targeted CAR-T Cell Therapy Market Size (2021-2032)
  2. 8.2 Europe CD19-targeted CAR-T Cell Therapy Market Size by Type
  3. 8.2.1 Europe CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe CD19-targeted CAR-T Cell Therapy Market Size by Application
  7. 8.3.1 Europe CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country
  11. 8.4.1 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China CD19-targeted CAR-T Cell Therapy Market Size (2021-2032)
  2. 9.2 China CD19-targeted CAR-T Cell Therapy Market Size by Type
  3. 9.2.1 China CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032)
  6. 9.3 China CD19-targeted CAR-T Cell Therapy Market Size by Application
  7. 9.3.1 China CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia CD19-targeted CAR-T Cell Therapy Market Size (2021-2032)
  2. 10.2 Asia CD19-targeted CAR-T Cell Therapy Market Size by Type
  3. 10.2.1 Asia CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia CD19-targeted CAR-T Cell Therapy Market Size by Application
  7. 10.3.1 Asia CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia CD19-targeted CAR-T Cell Therapy Market Size by Country
  11. 10.4.1 Asia CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst